关键数据
1.580今开
1.595最高
6.94K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.01%换手率
1.585昨收
1.550最低
10.90K成交额
亏损市盈率静
8.14市净率
0.00%股息率 TTM
-31.56%ROA
4.19152周最高
33.34量比
-251.39M净利润
76.46M总股本
-1.7653每股收益TTM
1.65Beta
-191.81%ROE
1.09052周最低
2.84%振幅
100.00%毛利率
120.43M总市值
0.09回报/风险
6.81%风险率

即将为您带来更多新闻,敬请期待。。。
Cibus Inc评分
-0.47与上次评分对比预测7.33
财务诊断5.14
技术分析3.58
公司估值7.70
机构认同度3.00
风险评估2.21
分析师评级
买入评级
14.000目标均价
+780.50%涨幅空间
Cibus Inc 最新财报电话会记录
Cibus (CBUS) 2026财年第二季度业绩电话会议:随着成本下降,水稻产品发布推迟至2028年
随着成本下降,Cibus (CBUS) 2026年第二季度营收达到100万美元;同时,其拉丁美洲水稻上市计划推迟至2028年,现金支撑期延长至2027年第一季度初。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
Cibus Inc 简介
Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
行业医疗设备与耗材
公司代码CBUS
员工数量157
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| Riggs (Rory B) | 19.61% |
|---|
| Fidelity Management & Research Company LLC | 9.57% |
|---|
| Vanguard Capital Management, LLC | 2.78% |
|---|
| JPL Investments SA | 2.21% |
|---|
| 股东类型 | 占比 |
|---|
| Individual Investor | 22.51% |
|---|
| Investment Advisor | 14.29% |
|---|
| Corporation | 2.21% |
|---|
| Investment Advisor/Hedge Fund | 2.17% |
|---|
常见问题
Cibus Inc(CBUS)的当前股价是多少?
Cibus Inc(CBUS)的当前股价是 1.57。
现在Cibus Inc(CBUS)的股票是买入、持有还是卖出?
根据分析师评级,Cibus Inc(CBUS)的总体评级为买入,目标价格为14.00。
Cibus Inc(CBUS)股票的每股收益(EPS TTM)是多少
Cibus Inc(CBUS)股票的每股收益(EPS TTM)是-1.77。